News for Healthier Living

Wistar Scientists Develop DNA-delivered Immunotherapy that Targets Ovarian Cancer More Effectively

Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies.

July 17, 2026


July 21 2026

July 20 2026

July 17 2026

July 16 2026

July 15 2026

July 14 2026

July 13 2026

July 12 2026

July 10 2026

July 9 2026

July 8 2026

July 7 2026